Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.12
-0.23 (-2.46%)
At close: Nov 4, 2024, 4:00 PM
9.15
+0.03 (0.33%)
Pre-market: Nov 5, 2024, 7:02 AM EST
Novavax Employees
Novavax had 1,543 employees as of December 31, 2023. The number of employees decreased by 449 or -22.54% compared to the previous year.
Employees
1,543
Change (1Y)
-449
Growth (1Y)
-22.54%
Revenue / Employee
$640,095
Profits / Employee
-$190,754
Market Cap
1.46B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Evotec SE | 5,061 |
AMN Healthcare Services | 3,585 |
STAAR Surgical Company | 1,057 |
InMode | 581 |
Arcus Biosciences | 577 |
Progyny | 566 |
BioCryst Pharmaceuticals | 536 |
Ardelyx | 267 |
NVAX News
- 14 hours ago - Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 - PRNewsWire
- 5 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Novavax, Inc. (NVAX) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 6 days ago - Novavax, Inc. (NVAX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 7 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Novavax, Inc. (NVAX) Shareholders to Inquire about Securities Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Novavax, Inc. (NVAX) And Encourages Investors to Connect - Accesswire
- 12 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Novavax, Inc. (NVAX) Stockholders to Inquire about Securities Investigation - Accesswire
- 13 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Novavax, Inc. (NVAX) and Encourages Investors to Learn More About the Investigation - Accesswire
- 14 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novavax, Inc. (NVAX) And Encourages Investors to Reach Out - Accesswire